Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: “The water affects everyone,” she said, which is why she believes her job is so important. Reese is studying public health and environmental health at East Carolina University in North Carolina. She will be an intern for the East Shore department, working on the Connecticut shoreline until the end of July. Reese spends her Tuesday mornings driving around to all the public and private natural swimming areas in Branford, North Branford and East Haven, collecting water samples and putting them on ice in her purple cooler. The samples are then collected by state Department of Public Health couriers and brought to the state lab in Rocky Hill for testing. Water quality testing has always been a priority for the East Shore department every summer, but this year, Alex Cinotti, the assistant director of health, has something he’s trying to prove. Every year, from Memorial Day to Labor Day, the department collects weekly water samples from 12 water bodies used for swimming, both freshwater and saltwater, to ensure bacteria levels are low enough for public safety. Samples are collected and tested once a week, and as long as bacteria levels fall below state-determined risk levels, the beaches and other water bodies remain open. This year, however, Cinotti would like to take the sampling a step further — to show a direct correlation between rainfall and elevated bacteria levels, he said, as rain will often wash contaminants into public waters and cause bacteria levels to rise. “This is our opportunity to take samples and establish a pattern,” Cinotti said. “Bacteria is bacteria and we consider it pathogenic.” As such, in addition to the weekly sampling of water, Cinotti said that the department is collecting samples after heavy rains to see if bacteria levels rise after rainfall. This kind of analysis could not be done last summer, Cinotti said, because there were few rain events due to the drought. On the state level, the Department of Energy and Environmental Protection will close public beaches after a significant amount of rainfall, in anticipation of potentially higher bacteria levels. Scott Szalkiewicz, a health program supervisor for the state Health Department, told the Register last summer that because samples take 24 hours to process, it’s helpful to be able to close beaches before test results come in when officials believe bacteria levels will be high based on the amount of rain and visual indicators. The East Shore District Health Department serves Branford, North Branford and East Haven. The 12 bathing waters surveyed each week include the east and west East Haven beaches, the Clark Avenue beach, Branford Point, Stony Creek, Hotchkiss Grove, Turtle Bay, Sunrise Cove, Lanphier Cove, Cedar Lake, Linsley Lake and Clear Lake. According to water quality records from the East Shore District Health Department in 2016, there was only one time when bacteria levels reached a level at which one of the beaches had to close. Sunrise Cove reached a level of 1,000 colonies of bacteria in the sample of 100 milliliters of water on Aug. 2, 2016, according to the records. Cinotti said that the safe levels for salt water are 104 colonies of bacteria per 100 milliliters of water and 235 colonies for fresh water per 100 milliliters of water. Some things that cause heightened bacteria levels include wild animal and dog feces, sewer overflows and leaks, Cinotti said. Rain may wash contaminants such as sewer overflows, nitrogen-rich pollutants and goose and dog feces into the Sound and other bathing water bodies. Potential health risks from swimming in water with high levels of bacteria include possible infections to open wounds and gastrointestinal illness when water is accidentally swallowed, Cinotti said. He added that it’s possible swimmers could contract eye- or ear-related illnesses from high levels of bacteria. “We really need to protect children,” Cinotti said. “They are more vulnerable than adults.” ___ Online: http://bit.ly/2rFTp4s ___ Information from: New Haven Register, http://www.nhregister.com Claim: Officials study link between rain and bacteria in water.

Output: For Kellyn Reese, waking up on Tuesday mornings and going to the beach because it’s her job is a nice perk of being a summer intern at the East Shore District Health Department.


Input: Consider Input: Paragraph: Veggies given names like “zesty ginger-turmeric sweet potatoes” and “twisted citrus-glazed carrots” were more popular than those prepared exactly the same way but with plainer, more healthful-sounding labels. Diners more often said “no thanks” when the food had labels like “low-fat,” ″reduced-sodium” or “sugar-free.” More diners chose the fancy-named items, and selected larger portions of them too in the experiment last fall at a Stanford University cafeteria. “While it may seem like a good idea to emphasize the healthiness of vegetables, doing so may actually backfire,” said lead author Bradley Turnwald, a graduate student in psychology. Other research has shown that people tend to think of healthful sounding food as less tasty, so the aim was to make it sound as good as more indulgent, fattening fare. Researchers from Stanford’s psychology department tested the idea as a way to improve eating habits and make a dent in the growing obesity epidemic . “This novel, low-cost intervention could easily be implemented in cafeterias, restaurants, and consumer products to increase selection of healthier options,” they said. The results were published Monday JAMA Internal Medicine. The study was done over 46 days last fall. Lunchtime vegetable offerings were given different labels on different days. For example, on one day diners could choose “dynamite chili and tangy lime-seasoned beets.” On other days the same item was labeled “lighter-choice beets with no added sugar,” ″high antioxidant beets,” or simply “beets.” Almost one-third of the nearly 28,000 diners chose a vegetable offering during the study. The tasty-sounding offering was the most popular, selected by about 220 diners on average on days it was offered, compared with about 175 diners who chose the simple-label vegetable. The healthy-sounding labels were the least popular. Diners also served themselves bigger portions of the tasty-sounding vegetables than of the other choices. Turnwald emphasized that “there was no deception” —  all labels accurately described the vegetables, although diners weren’t told that the different-sounding choices were the exact same item. The results illustrate “the interesting advantage to indulgent labeling,” he said. Dr. Stephen Cook, a University of Rochester childhood obesity researcher, called the study encouraging and said some high school cafeterias have also tried different labels to influence healthy eating. “It shouldn’t be a surprise to us because marketing people have been doing this for years,” Cook said. ___ Follow AP Medical Writer Lindsey Tanner at http://www.twitter.com/LindseyTanner and her work can be found at http://tinyurl.com/kv4uhoh Claim: Sweet sizzlin’ beans! Fancy names may boost healthy  dining.

Output: Researchers tried a big serving of food psychology and a dollop of trickery to get diners to eat their vegetables. And it worked.


Input: Consider Input: Paragraph: The company has held back on marketing the pharmacy benefit plan while it talks to these groups, CVS said. The plan, launched a year ago, is based on analyses by the Institute for Clinical and Economic Review (ICER), a Boston-based group that assesses effectiveness of drugs to determine appropriate prices. Using ICER’s cost effectiveness assessment, CVS decides whether to include second or third medicines entering the market if there are already similar ones in the plan. Opposition to the CVS plan is part of much broader concerns cited by drug companies and advocacy groups, many of which receive funding from the pharmaceutical industry. Some say that ICER’s analysis based on additional years of “quality life” gained from a given treatment is arbitrary and disregards the costs of drug development and patient needs. More than 50 groups, including drugmakers, PhRMA, the industry’s main lobby group, and other advocacy groups, have provided comment during a public input period included in a review by ICER of its assessment methods. Many asked ICER to eliminate price recommendations from its efficacy analyses. ICER has defended its methods, which are based on a widely-used cost effectiveness analysis. The soft rollout of CVS’ ICER-related product comes as employer health plan sponsors - its biggest clients - are showing increased concern over their cost for new high-priced  drugs, and are considering refusing to pay for them at all, CVS Chief Medical Officer Troy Brennan said in a recent interview. If corporate customers follow through on that threat, CVS said it could change tactics with the plan. Rising drug prices, particularly for expensive specialty treatments for severe or deadly conditions, have pushed annual U.S. healthcare spending to $3.65 trillion, and made them unaffordable for many individuals. Earlier this year, Novartis AG (NOVN.S) launched Zolgensma, a more than $2 million gene therapy for a rare but deadly disease called spinal muscular atrophy. The new CVS program, cited as an example of ICER’s growing influence on U.S. drug pricing, would not apply to such a breakthrough treatment. It is a tiny plan by CVS standards as the company manages pharmaceutical benefits for more than 102 million people and also owns Aetna insurance and a national pharmacy chain. The plan’s scope is limited to so-called me too drugs, those where similar effective treatments already exist, and aims to pressure drugmakers to set lower prices. For example, two of three very similar drugs for migraine approved in 2018 could have been excluded, but drugmakers set prices ICER deemed cost effective. CVS has limited sales and marketing for the plan while it talks to patient groups who oppose it. About 240,000 CVS employees and a few large clients’ employees are enrolled thus far. The company declined to comment on exact membership. “We are not widely promoting this program,” Brennan said, adding that CVS is working to address patient groups’ concerns. Meanwhile, Brennan said some employers are considering  refusing to pay for million-dollar treatments like gene therapy. They are saying, “I’m not going to cover these kinds of therapies no matter what their comparative effectiveness is if they’ve got a really high cost.”  Large healthcare consultant and brokerage Mercer said it has begun to field similar concerns. “We have certainly gotten some plan sponsors saying ‘What if we don’t cover specialty drugs?’” said David Dross, who runs Mercer’s managed pharmacy practice. Two years ago, it never received any such questions, he said. Steve Wojcik, an executive with the National Business Group on Health which represents large employers, said he does not believe many will take that drastic step. Still, ICER President Steven Pearson said employers tell him they worry about their ability to cover everything and have suggested they might drop some high-cost treatments. He said employers can use cost effectiveness analysis to help them manage their spending. ICER has responded to outside criticism by meeting with patient advocates and by adding new measurements for a drug’s effectiveness, such as the value of life years gained, which does not focus on quality of life improvements, Pearson said. Since 2015, ICER has published up to a dozen reviews each year of drugs and classes of medicines. Most U.S. private insurers now use ICER clinical and cost analyses to inform coverage negotiations with drugmakers. ICER funding primarily comes from a non-profit foundation, but drug companies and health insurers provide some funds for ICER-related activities. Claim: CVS drug coverage plan based on outside pricing review is off to a slow start.


Output: A CVS Health Corp (CVS.N) health plan that uses an outside drug pricing group to help it decide whether to cover certain new medicines has gained little traction with customers, according to its top medical executive, and has drawn fierce criticism from patient advocacy groups.